Titre : Excipients pharmaceutiques

Excipients pharmaceutiques : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 2

#1

Comment identifier un excipient allergène ?

Des tests cutanés ou des analyses sanguines peuvent aider à identifier les allergies aux excipients.
Allergies médicamenteuses Tests cutanés
#2

Quels tests pour évaluer la tolérance aux excipients ?

Des études de tolérance peuvent inclure des tests de provocation ou des évaluations cliniques.
Tolérance médicamenteuse Études cliniques

Symptômes 2

#1

Quels symptômes d'une réaction aux excipients ?

Les symptômes incluent éruptions cutanées, démangeaisons, ou troubles gastro-intestinaux.
Réactions cutanées Troubles gastro-intestinaux
#2

Les excipients peuvent-ils causer des nausées ?

Oui, certains excipients peuvent provoquer des nausées ou des vomissements chez certains patients.
Nausées Vomissements

Prévention 2

#1

Comment prévenir les réactions aux excipients ?

Il est essentiel de bien lire les étiquettes et de consulter un professionnel de santé.
Prévention des allergies Consultation médicale
#2

Les patients doivent-ils signaler des allergies ?

Oui, il est crucial que les patients informent leur médecin de toute allergie connue aux excipients.
Allergies médicamenteuses Antécédents médicaux

Traitements 2

#1

Comment traiter une allergie aux excipients ?

Le traitement inclut l'évitement de l'excipient et l'utilisation d'antihistaminiques si nécessaire.
Antihistaminiques Allergies médicamenteuses
#2

Peut-on remplacer un excipient problématique ?

Oui, il est possible de remplacer un excipient par un autre mieux toléré dans la formulation.
Formulation pharmaceutique Substituts

Complications 2

#1

Quelles complications peuvent survenir avec des excipients ?

Des complications peuvent inclure des réactions sévères comme le choc anaphylactique ou des troubles respiratoires.
Choc anaphylactique Réactions sévères
#2

Les excipients peuvent-ils aggraver des maladies ?

Oui, certains excipients peuvent aggraver des conditions comme l'asthme ou l'insuffisance rénale.
Asthme Insuffisance rénale

Facteurs de risque 2

#1

Qui est à risque d'allergies aux excipients ?

Les personnes ayant des antécédents d'allergies médicamenteuses sont plus à risque.
Antécédents médicaux Allergies médicamenteuses
#2

Les enfants sont-ils plus sensibles aux excipients ?

Oui, les enfants peuvent être plus sensibles aux excipients en raison de leur système immunitaire immature.
Enfants Système immunitaire
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Excipients pharmaceutiques : Questions médicales les plus fréquentes", "headline": "Excipients pharmaceutiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Excipients pharmaceutiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-21", "dateModified": "2026-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Excipients pharmaceutiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Utilisations spécialisées de produits chimiques", "url": "https://questionsmedicales.fr/mesh/D020313", "about": { "@type": "MedicalCondition", "name": "Utilisations spécialisées de produits chimiques", "code": { "@type": "MedicalCode", "code": "D020313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adjuvants pharmaceutiques", "alternateName": "Adjuvants, Pharmaceutic", "url": "https://questionsmedicales.fr/mesh/D000277", "about": { "@type": "MedicalCondition", "name": "Adjuvants pharmaceutiques", "code": { "@type": "MedicalCode", "code": "D000277", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.064" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Adjuvants vaccinaux", "alternateName": "Adjuvants, Vaccine", "url": "https://questionsmedicales.fr/mesh/D000089582", "about": { "@type": "MedicalCondition", "name": "Adjuvants vaccinaux", "code": { "@type": "MedicalCode", "code": "D000089582", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.064.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Agents aversifs", "alternateName": "Aversive Agents", "url": "https://questionsmedicales.fr/mesh/D000075528", "about": { "@type": "MedicalCondition", "name": "Agents aversifs", "code": { "@type": "MedicalCode", "code": "D000075528", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.179" } } }, { "@type": "MedicalWebPage", "name": "Excipients pour pommade", "alternateName": "Ointment Bases", "url": "https://questionsmedicales.fr/mesh/D009823", "about": { "@type": "MedicalCondition", "name": "Excipients pour pommade", "code": { "@type": "MedicalCode", "code": "D009823", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.523" } } }, { "@type": "MedicalWebPage", "name": "Excipients", "alternateName": "Excipients", "url": "https://questionsmedicales.fr/mesh/D005079", "about": { "@type": "MedicalCondition", "name": "Excipients", "code": { "@type": "MedicalCode", "code": "D005079", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.770.419" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Excipients vaccinaux", "alternateName": "Vaccine Excipients", "url": "https://questionsmedicales.fr/mesh/D000079282", "about": { "@type": "MedicalCondition", "name": "Excipients vaccinaux", "code": { "@type": "MedicalCode", "code": "D000079282", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.770.419.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Conservateurs pharmaceutiques", "alternateName": "Preservatives, Pharmaceutical", "url": "https://questionsmedicales.fr/mesh/D011310", "about": { "@type": "MedicalCondition", "name": "Conservateurs pharmaceutiques", "code": { "@type": "MedicalCode", "code": "D011310", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720.744.771" } } } ], "about": { "@type": "MedicalCondition", "name": "Excipients pharmaceutiques", "alternateName": "Pharmaceutic Aids", "code": { "@type": "MedicalCode", "code": "D010592", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michele B Kaufman", "url": "https://questionsmedicales.fr/author/Michele%20B%20Kaufman", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Kazuki Kushida", "url": "https://questionsmedicales.fr/author/Kazuki%20Kushida", "affiliation": { "@type": "Organization", "name": "Showa Pharmaceutical University." } }, { "@type": "Person", "name": "Masayoshi Hirohara", "url": "https://questionsmedicales.fr/author/Masayoshi%20Hirohara", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Mary Choy", "url": "https://questionsmedicales.fr/author/Mary%20Choy", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Bingnan Wang", "url": "https://questionsmedicales.fr/author/Bingnan%20Wang", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Development of a pharmaceutical database as an aid to the nonclinical detection of drug-induced cardiac toxicity.", "datePublished": "2024-04-16", "url": "https://questionsmedicales.fr/article/38636673", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vascn.2024.107507" } }, { "@type": "ScholarlyArticle", "name": "Stereoselective Crystallization of Chiral Pharmaceuticals Aided by Cellulose Derivatives through Helical Pattern Matching.", "datePublished": "2024-06-25", "url": "https://questionsmedicales.fr/article/38925570", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/chem.202401550" } }, { "@type": "ScholarlyArticle", "name": "Chemometrically-aided general approach to novel adsorbents studies: Case study on the adsorption of pharmaceuticals by the carbonized", "datePublished": "2024-07-18", "url": "https://questionsmedicales.fr/article/39149065", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2024.e34841" } }, { "@type": "ScholarlyArticle", "name": "Computer-Aided formulation design for pharmaceutical drug product development, part 01: Materials exploration through a visualization tool.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39481812", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijpharm.2024.124891" } }, { "@type": "ScholarlyArticle", "name": "Pharmaceuticals in hospital wastewaters: an analysis of the UBA's pharmaceutical database.", "datePublished": "2023-08-23", "url": "https://questionsmedicales.fr/article/37610546", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11356-023-29214-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Excipients pharmaceutiques", "item": "https://questionsmedicales.fr/mesh/D010592" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Excipients pharmaceutiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Excipients pharmaceutiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Excipients pharmaceutiques", "description": "Comment identifier un excipient allergène ?\nQuels tests pour évaluer la tolérance aux excipients ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Excipients pharmaceutiques", "description": "Quels symptômes d'une réaction aux excipients ?\nLes excipients peuvent-ils causer des nausées ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Excipients pharmaceutiques", "description": "Comment prévenir les réactions aux excipients ?\nLes patients doivent-ils signaler des allergies ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Excipients pharmaceutiques", "description": "Comment traiter une allergie aux excipients ?\nPeut-on remplacer un excipient problématique ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Excipients pharmaceutiques", "description": "Quelles complications peuvent survenir avec des excipients ?\nLes excipients peuvent-ils aggraver des maladies ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Excipients pharmaceutiques", "description": "Qui est à risque d'allergies aux excipients ?\nLes enfants sont-ils plus sensibles aux excipients ?", "url": "https://questionsmedicales.fr/mesh/D010592#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier un excipient allergène ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests cutanés ou des analyses sanguines peuvent aider à identifier les allergies aux excipients." } }, { "@type": "Question", "name": "Quels tests pour évaluer la tolérance aux excipients ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des études de tolérance peuvent inclure des tests de provocation ou des évaluations cliniques." } }, { "@type": "Question", "name": "Quels symptômes d'une réaction aux excipients ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent éruptions cutanées, démangeaisons, ou troubles gastro-intestinaux." } }, { "@type": "Question", "name": "Les excipients peuvent-ils causer des nausées ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains excipients peuvent provoquer des nausées ou des vomissements chez certains patients." } }, { "@type": "Question", "name": "Comment prévenir les réactions aux excipients ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Il est essentiel de bien lire les étiquettes et de consulter un professionnel de santé." } }, { "@type": "Question", "name": "Les patients doivent-ils signaler des allergies ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est crucial que les patients informent leur médecin de toute allergie connue aux excipients." } }, { "@type": "Question", "name": "Comment traiter une allergie aux excipients ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'évitement de l'excipient et l'utilisation d'antihistaminiques si nécessaire." } }, { "@type": "Question", "name": "Peut-on remplacer un excipient problématique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il est possible de remplacer un excipient par un autre mieux toléré dans la formulation." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des excipients ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des complications peuvent inclure des réactions sévères comme le choc anaphylactique ou des troubles respiratoires." } }, { "@type": "Question", "name": "Les excipients peuvent-ils aggraver des maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains excipients peuvent aggraver des conditions comme l'asthme ou l'insuffisance rénale." } }, { "@type": "Question", "name": "Qui est à risque d'allergies aux excipients ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies médicamenteuses sont plus à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus sensibles aux excipients ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux excipients en raison de leur système immunitaire immature." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 11/04/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Michele B Kaufman

5 publications dans cette catégorie

Publications dans "Excipients pharmaceutiques" :

Kazuki Kushida

2 publications dans cette catégorie

Affiliations :
  • Showa Pharmaceutical University.
Publications dans "Excipients pharmaceutiques" :

Masayoshi Hirohara

2 publications dans cette catégorie

Publications dans "Excipients pharmaceutiques" :

Mary Choy

2 publications dans cette catégorie

Publications dans "Excipients pharmaceutiques" :

Bingnan Wang

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China.
Publications dans "Excipients pharmaceutiques" :

Shanshan Liu

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China.
Publications dans "Excipients pharmaceutiques" :

Xiaolin Liu

1 publication dans cette catégorie

Affiliations :
  • Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Centre for Tissue Restoration and Reconstruction, Institute for Advanced Study, and Department of Chemical and Biological Engineering, The Hong Kong University of Science & Technology, Clear Water Bay, Kowloon, Hong Kong, 999077, China.
Publications dans "Excipients pharmaceutiques" :

Rong Hu

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China.
Publications dans "Excipients pharmaceutiques" :

Anjun Qin

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China.
Publications dans "Excipients pharmaceutiques" :

Ben Zhong Tang

1 publication dans cette catégorie

Affiliations :
  • State Key Laboratory of Luminescent Materials and Devices, Guangdong Provincial Key Laboratory of Luminescence from Molecular Aggregates, Center for Aggregation-Induced Emission, South China University of Technology, Guangzhou, 510640, China.
  • Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Centre for Tissue Restoration and Reconstruction, Institute for Advanced Study, and Department of Chemical and Biological Engineering, The Hong Kong University of Science & Technology, Clear Water Bay, Kowloon, Hong Kong, 999077, China.
  • Shenzhen Institute of Molecular Aggregate Science and Engineering, School of Science and Engineering, The Chinese University of Hong Kong, Shenzhen, 2001 Longxiang Boulevard, Longgang District, Shenzhen City, Guangdong, 518172, China.
Publications dans "Excipients pharmaceutiques" :

Michael Chaiton

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Lori M Diemert

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Susan J Bondy

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Joanna E Cohen

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
  • Health, Behavior and Society Department, Johns Hopkins Bloomberg School of Public Health, Baltimore, ML.
Publications dans "Excipients pharmaceutiques" :

Michael D Fung

1 publication dans cette catégorie

Affiliations :
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Bo R Zhang

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Roberta G Ferrence

1 publication dans cette catégorie

Affiliations :
  • Ontario Tobacco Research Unit, University of Toronto, Toronto, ON.
  • Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Publications dans "Excipients pharmaceutiques" :

Donald De Alwis

1 publication dans cette catégorie

Affiliations :
  • Health and Environmental Sciences Institute, Washington, DC 20005, USA.
Publications dans "Excipients pharmaceutiques" :

C Michael Foley

1 publication dans cette catégorie

Affiliations :
  • Abbvie Inc., North Chicago, IL 60064, USA. Electronic address: Michael.Foley@abbvie.com.
Publications dans "Excipients pharmaceutiques" :

Eugene Herman

1 publication dans cette catégorie

Affiliations :
  • National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: eugene.herman2@nih.gov.
Publications dans "Excipients pharmaceutiques" :

Sources (4920 au total)

Impact of pharmaceutical and non-pharmaceutical interventions on COVID-19 in Tunisia.

In COVID-19 management, a variety of pharmaceutical interventions (PI) and non- pharmaceutical interventions (NPI) were adopted to limit the spread of the disease and its associated deaths. We aimed t... We collected aggregate data from March 2nd, 2020, to December 1, 2022 from the Tunisian Ministry of Health's website and OurWorldInData.org site. NPI Periods (NPIP: March 2020 to March 2021) and PI Pe... The risk of SARS-CoV-2 transmission increased progressively from the zero cases period (NPIP2) to the mitigate strategy period (NPIP3) (RR = 14.0; 95% CI: 12.4-15.8) and to the stop-and-go epidemic co... In terms of lowering the risk of transmission and mortality, the NP strategy at the beginning of the epidemic outperformed the IP strategy during the outbreak....